2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy

Michael N. Neuss

Martha Polovich

Kristen McNiff

Peg Esper

Terry R. Gilmore

Kristine B. LeFebvre

Lisa Schulmeister

Joseph O. Jacobson

oral chemotherapy, safe handling, safety, standards and guidelines
ONF 2013, 40(3), 225-233. DOI: 10.1188/13.ONF.40-03AP2

In 2009, the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society (ONS) published standards for the safe use of parenteral chemotherapy in the outpatient setting, including issues of practitioner orders, preparation, and administration of medication. In 2011, these were updated to include inpatient facilities. In December 2011, a multistakeholder workgroup met to address the issues associated with orally administered antineoplastics, under the leadership of ASCO and ONS. The workgroup participants developed recommended standards, which were presented for public comment. Public comments informed final edits, and the final standards were reviewed and approved by the ASCO and ONS Boards of Directors. Significant newly identified recommendations include those associated with drug prescription and the necessity of ascertaining that prescriptions are filled. In addition, the importance of patient and family education regarding administration schedules, exception procedures, disposal of unused oral medication, and aspects of continuity of care across settings were identified. This article presents the newly developed standards.

Jump to a section


    Jacobson JO, Polovich M, McNiff KK, et al: American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 27: 5469-5475, 2009
    Jacobson JO, Polovich M, Gilmore TR, et al: Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: Expanding the scope to include inpatient settings. J Oncol Pract 8: 2-6, 2012
    Halfdanarson TR, Jatoi A: Oral cancer chemotherapy: The critical interplay between patient education and patient safety. Curr Oncol Rep 12:247-252, 2010
    Irshad S, Maisey N: Considerations when choosing oral chemotherapy: Identifying and responding to patient need. Eur J Canc Care 19:5-511, 2010
    Weingart SN, Toro J, Spencer J, et al: Medication errors involving oral chemotherapy. Cancer 116:2455-52464, 2010
    Ruddy K, Mayer E, Partridge A: Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59:56-66, 2009
    Hartigan K: Patient education: The cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7:21-524, 2003
    Highland J, Clemens H, et al: Mandated benefit review of SB 1070: An act relative to oral cancer therapy. Compass Health Analytics, 2012,
    Weingart S, Brown E, Bach PB, et al: NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw 6: S1-S14, 2008 (suppl 3)
    Liu G, Franssen E, Fitch MI, et al: Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15:110-5115, 1997
    Wong SF, Nguyen CP, et al: Outcome assessment of an oral chemotherapy management clinic: A preliminary report. J Clin Oncol 30, 2012 (suppl 34; abstr 105)
    McNiff KK, Bonelli KR, Jacobson JO: Quality Oncology Practice Initiative certification program: Overview, measure scoring methodology, and site assessment standards. J Oncol Pract 5:270-276, 2009
    Bedell C: A changing paradigm for cancer treatment: The advent of new oral chemotherapy agents. Clin J Oncol Nurs 7:5-9, 2003
    Markert A, Thierry V, Kieber M, et al: Chemotherapy safety and severe adverse events in cancer patients: Strategies to efficiently avoid chemotherapy errors in inand outpatient treatment. Intl J Canc 124:722-728, 2009
    Lilleyman JS, Lennard L: Non-compliance with oral chemotherapy in childhood leukaemia. BMJ 313:1219, 1996
    Landier W: Adherence to oral chemotherapy in childhood acute lymphoblastic leukemia: An evolutionary concept analysis. Oncol Nurs Forum 38:343-352, 2011
    Hede K: Increase in oral cancer drugs raises thorny issues for oncology practices. J Natl Cancer Inst 101:1534-1526, 2009
    Neugut A, Subar M, Wilde ET, et al: Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29: 2534-2542, 2011